{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:27:46Z","timestamp":1790328466096,"version":"4.1.0"},"reference-count":241,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["642414"],"award-info":[{"award-number":["642414"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jconrel.2020.08.041","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T02:23:37Z","timestamp":1598495017000},"page":"985-999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Drug delivery in intervertebral disc degeneration and osteoarthritis: Selecting the optimal platform for the delivery of disease-modifying agents"],"prefix":"10.1016","volume":"328","author":[{"given":"Fabio","family":"Colella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4837-0401","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-4388","authenticated-orcid":false,"given":"Marco","family":"Sorbona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"D'Atri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian P.Y.","family":"Barr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Oieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Letizia","family":"Vainieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Zerrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Capar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"H\u00e4ckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1585-3052","authenticated-orcid":false,"given":"Laura B.","family":"Creemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jconrel.2020.08.041_bb0005","first-page":"646","article-title":"Burden of major musculoskeletal conditions","volume":"81","author":"Woolf","year":"2003","journal-title":"Bull. World Health Organ."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cger.2010.03.001","article-title":"Epidemiology of osteoarthritis","volume":"26","author":"Zhang","year":"2010","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coph.2015.03.004","article-title":"Emerging targets in osteoarthritis therapy","volume":"22","author":"Goldring","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0020","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrrheum.2013.44","article-title":"Biologic agents in osteoarthritis: hopes and disappointments","volume":"9","author":"Chevalier","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/ar629","article-title":"Degeneration of the intervertebral disc","volume":"5","author":"Urban","year":"2003","journal-title":"Arthrit. Res. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrrheum.2013.159","article-title":"Progress in intra-articular therapy","volume":"10","author":"Evans","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.addr.2014.10.024","article-title":"Delivery systems for the treatment of degenerated intervertebral discs","volume":"84","author":"Blanquer","year":"2015","journal-title":"Adv. Drug Del. Rev."},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.041_bb0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/ten.teb.2010.0191","article-title":"Articular cartilage: structure and regeneration","volume":"16","author":"Becerra","year":"2010","journal-title":"Tissue Eng. Part B Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.csm.2017.02.001","article-title":"Basic science of articular cartilage","volume":"36","author":"Carballo","year":"2017","journal-title":"Clin. Sports Med."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/1874312901105010100","article-title":"The normal synovium","volume":"5","author":"Smith","year":"2011","journal-title":"Open Rheumatol. J."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ar.1092200402","article-title":"Human intervertebral-disk - structure and function","volume":"220","author":"Humzah","year":"1988","journal-title":"Anat. Rec."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12178-014-9253-8","article-title":"Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics","volume":"8","author":"Weber","year":"2015","journal-title":"Curr. Rev. Musculoskelet. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/ar380","article-title":"Collagen of articular cartilage","volume":"4","author":"Eyre","year":"2002","journal-title":"Arthrit. Res. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2519\/jospt.1998.28.4.192","article-title":"Articular cartilage: injuries and potential for healing","volume":"28","author":"Buckwalter","year":"1998","journal-title":"J. Orthop. Sports Phys. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0075","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/ard.49.7.536","article-title":"Influence of cyclic loading on the nutrition of articular cartilage","volume":"49","author":"O\u2019Hara","year":"1990","journal-title":"Ann. Rheum. Dis."},{"issue":"18","key":"10.1016\/j.jconrel.2020.08.041_bb0080","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1097\/01.brs.0000231761.73859.2c","article-title":"What is intervertebral disc degeneration, and what causes it?","volume":"31","author":"Adams","year":"2006","journal-title":"Spine"},{"issue":"23","key":"10.1016\/j.jconrel.2020.08.041_bb0085","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1097\/01.brs.0000148014.15210.64","article-title":"ISSLS prize winner: a study of diffusion in human lumbar discs: a serial magnetic resonance imaging study documenting the influence of the endplate on diffusion in normal and degenerate discs","volume":"29","author":"Rajasekaran","year":"2004","journal-title":"Spine (Phila Pa 1976)"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0090","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcp.21258","article-title":"Osteoarthritis","volume":"213","author":"Goldring","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.jconrel.2020.08.041_bb0095","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I","article-title":"The role of the chondrocyte in osteoarthritis","volume":"43","author":"Goldring","year":"2000","journal-title":"Arthrit. Rheumatol."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb0100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0b013e328349c2b1","article-title":"Inflammation in osteoarthritis","volume":"23","author":"Goldring","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.spinee.2012.12.003","article-title":"The molecular basis of intervertebral disc degeneration","volume":"13","author":"Kepler","year":"2013","journal-title":"Spine J."},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.041_bb0110","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"427 Suppl","key":"10.1016\/j.jconrel.2020.08.041_bb0115","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/01.blo.0000143818.74887.b1","article-title":"Chondrocyte senescence, joint loading and osteoarthritis","author":"Martin","year":"2004","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/978-981-13-0950-2_21","article-title":"Biomechanics in annulus fibrosus degeneration and regeneration","volume":"1078","author":"Chu","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9072","key":"10.1016\/j.jconrel.2020.08.041_bb0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0140-6736(97)02135-1","article-title":"Nerve ingrowth into diseased intervertebral disc in chronic back pain","volume":"350","author":"Freemont","year":"1997","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb0130","first-page":"4","article-title":"The aging spine: the role of inflammatory mediators in intervertebral disc degeneration","volume":"53","author":"Podichetty","year":"2007","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1302\/0301-620X.79B1.0790147","article-title":"Sensory and sympathetic innervation of the vertebral endplate in patients with degenerative disc disease","volume":"79","author":"Brown","year":"1997","journal-title":"J. Bone Joint Surg. Br."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jor.1100120318","article-title":"Scanning electron microscopic observations of the vascular structure of vertebral end-plates in rabbits","volume":"12","author":"Oki","year":"1994","journal-title":"J. Orthop. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0145","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI95147","article-title":"Senescent cells and osteoarthritis: a painful connection","volume":"128","author":"Jeon","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.041_bb0150","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm.4324","article-title":"Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment","volume":"23","author":"Jeon","year":"2017","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb0155","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/rheumatology\/keh127","article-title":"Recovery of function in osteoarthritic chondrocytes induced by p16(INK4a)-specific siRNA in vitro","volume":"43","author":"Zhou","year":"2004","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.jconrel.2020.08.041_bb0160","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.joca.2012.07.022","article-title":"Osteoarthritis year 2012 in review: clinical","volume":"20","author":"Hochberg","year":"2012","journal-title":"Osteoarthr. Cartil."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"7555","key":"10.1016\/j.jconrel.2020.08.041_bb0170","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/bmj.332.7555.1430","article-title":"Diagnosis and treatment of low back pain","volume":"332","author":"Koes","year":"2006","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.jconrel.2020.08.041_bb0175","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.041_bb0180","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/ard.2003.017236","article-title":"Paracetamol in osteoarthritis of the knee","volume":"63","author":"Miceli-Richard","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthr. Cartil."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0190","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1517\/17425247.2014.867325","article-title":"Drug delivery systems for intra-articular treatment of osteoarthritis","volume":"11","author":"Kang","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0195","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M17-0293","article-title":"Management of low back pain: getting from evidence-based recommendations to high-value care","volume":"166","author":"Atlas","year":"2017","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.semarthrit.2007.10.004","article-title":"COX-2 selective inhibitors in the treatment of osteoarthritis","volume":"38","author":"Laine","year":"2008","journal-title":"Semin. Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bpg.2009.11.005","article-title":"Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract","volume":"24","author":"Sostres","year":"2010","journal-title":"Best Pract. Res Cl Ga"},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0210","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0885-3924(02)00629-2","article-title":"Gastrointestinal effects of NSAIDs and coxibs","volume":"25","author":"Laine","year":"2003","journal-title":"J. Pain Symptom Manag."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jpainsymman.2003.10.015","article-title":"A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain","volume":"28","author":"Schnitzer","year":"2004","journal-title":"J. Pain Symptom Manag."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2020.08.041_bb0220","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1007\/s00586-006-1072-1","article-title":"Chapter 4. European guidelines for the management of chronic nonspecific low back pain","volume":"15","author":"Airaksinen","year":"2006","journal-title":"Eur. Spine J."},{"issue":"17","key":"10.1016\/j.jconrel.2020.08.041_bb0225","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1097\/01.BRS.0000090503.38830.AD","article-title":"Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration","volume":"28","author":"van Tulder","year":"2003","journal-title":"Spine (Phila Pa 1976)"},{"issue":"9783","key":"10.1016\/j.jconrel.2020.08.041_bb0230","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","article-title":"Osteoarthritis: an update with relevance for clinical practice","volume":"377","author":"Bijlsma","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pain.2004.02.019","article-title":"Potent opioids for chronic musculoskeletal pain: flying blind?","volume":"109","author":"Von Korff","year":"2004","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0240","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-147-7-200710020-00006","article-title":"Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society","volume":"147","author":"Chou","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0245","article-title":"Intraarticular corticosteroid for treatment of osteoarthritis of the knee","author":"Bellamy","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pmr.2010.10.006","article-title":"The efficacy of lumbar epidural steroid injections: transforaminal, interlaminar, and caudal approaches","volume":"22","author":"Rho","year":"2011","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0255","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.addr.2006.01.018","article-title":"Intraarticular drug delivery in osteoarthritis","volume":"58","author":"Gerwin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002018-200023020-00003","article-title":"A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee","volume":"23","author":"Adams","year":"2000","journal-title":"Drug Saf."},{"issue":"12","key":"10.1016\/j.jconrel.2020.08.041_bb0265","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrrheum.2013.141","article-title":"Platelet-rich plasma for managing pain and inflammation in osteoarthritis","volume":"9","author":"Andia","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0270","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00441-019-02996-x","article-title":"The use of PRP injections in the management of knee osteoarthritis","volume":"376","author":"O\u2019Connell","year":"2019","journal-title":"Cell Tissue Res."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0275","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/pm\/pnz011","article-title":"Meta-analysis comparing platelet-rich plasma vs hyaluronic acid injection in patients with knee osteoarthritis","volume":"20","author":"Han","year":"2019","journal-title":"Pain Med."},{"issue":"11","key":"10.1016\/j.jconrel.2020.08.041_bb0280","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthr. Cartil."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb0285","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/neuros\/nyw162","article-title":"Lumbar fusion for degenerative disease: a systematic review and meta-analysis","volume":"80","author":"Yavin","year":"2017","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0290","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.knee.2016.02.001","article-title":"Autologous chondrocyte implantation (ACI) for cartilage defects of the knee: a guideline by the working group \u201cClinical Tissue Regeneration\u201d of the German Society of Orthopaedics and Trauma (DGOU)","volume":"23","author":"Niemeyer","year":"2016","journal-title":"Knee"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11999-009-0998-0","article-title":"Autologous chondrocyte implantation for joint preservation in patients with early osteoarthritis","volume":"468","author":"Minas","year":"2010","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb0300","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00264-010-0959-y","article-title":"Treatment of articular cartilage lesions of the knee","volume":"34","author":"Falah","year":"2010","journal-title":"Int. Orthop."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coph.2015.03.004","article-title":"Emerging targets in osteoarthritis therapy","volume":"22","author":"Goldring","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb0310","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.joca.2014.03.004","article-title":"The hallmarks of osteoarthritis and the potential to develop personalised disease-modifying pharmacological therapeutics","volume":"22","author":"Tonge","year":"2014","journal-title":"Osteoarthr. Cartil."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0315","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14728214.2011.576670","article-title":"Emerging drugs for osteoarthritis","volume":"16","author":"Matthews","year":"2011","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0320","doi-asserted-by":"crossref","DOI":"10.1186\/ar1932","article-title":"Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow","volume":"8","author":"Pelletier","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0325","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/polym6030799","article-title":"Drugs and polymers for delivery systems in OA joints: clinical needs and opportunities","volume":"6","author":"Janssen","year":"2014","journal-title":"Polymers-Basel"},{"issue":"16","key":"10.1016\/j.jconrel.2020.08.041_bb0330","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","article-title":"Tanezumab for the treatment of pain from osteoarthritis of the knee","volume":"363","author":"Lane","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.041_bb0335","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.joca.2011.01.009","article-title":"Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain","volume":"19","author":"Schnitzer","year":"2011","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0340","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/JPR.S135257","article-title":"Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis","volume":"11","author":"Birbara","year":"2018","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0345","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2019.8044","article-title":"Effect of Tanezumab on joint pain, physical function, and patient global assessment of osteoarthritis among patients with osteoarthritis of the hip or knee: a randomized clinical trial","volume":"322","author":"Schnitzer","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0350","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthrit. Rheum."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0355","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/ar3430","article-title":"A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee","volume":"13","author":"Cohen","year":"2011","journal-title":"Arthrit. Res. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0360","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.40840","article-title":"A phase II trial of lutikizumab, an anti-interleukin-1alpha\/beta dual variable domain immunoglobulin, in knee osteoarthritis patients with synovitis","volume":"71","author":"Fleischmann","year":"2019","journal-title":"Arthrit. Rheumatol."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0365","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/annrheumdis-2018-213336","article-title":"Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1alpha and anti-interleukin-1beta dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis","volume":"78","author":"Kloppenburg","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb0370","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/ALN.0b013e3181a05aa0","article-title":"Randomized, double-blind, placebo-controlled, dose-response, and preclinical safety study of transforaminal epidural etanercept for the treatment of sciatica","volume":"110","author":"Cohen","year":"2009","journal-title":"Anesthesiology"},{"issue":"11","key":"10.1016\/j.jconrel.2020.08.041_bb0375","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/jor.21165","article-title":"Intra-articular injections of bone morphogenetic protein-7 retard progression of existing cartilage degeneration","volume":"28","author":"Hayashi","year":"2010","journal-title":"J. Orthop. Res."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0380","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.38614","article-title":"Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial","volume":"66","author":"Lohmander","year":"2014","journal-title":"Arthrit. Rheumatol."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0385","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/ard.2010.147967","article-title":"The effects of doxycycline on reducing symptoms in knee osteoarthritis: results from a triple-blinded randomised controlled trial","volume":"70","author":"Snijders","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb0390","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/ar2315","article-title":"Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study","volume":"9","author":"Krzeski","year":"2007","journal-title":"Arthrit. Res. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0395","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/annrheumdis-2012-202239","article-title":"A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee","volume":"72","author":"Hellio le Graverand","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.jconrel.2020.08.041_bb0400","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.joca.2017.07.006","article-title":"A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study","volume":"25","author":"Yazici","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0405","first-page":"1146","article-title":"Results from a 52 week randomised, double-blind, placebo-controlled, phase 2 study of a novel, Wnt pathway inhibitor (Sm04690) for knee osteoarthritis treatment","volume":"77","author":"Yazici","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0410","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.joca.2014.12.019","article-title":"Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials","volume":"23","author":"Karsdal","year":"2015","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0415","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0300060517723182","article-title":"Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: an open-label randomized controlled trial","volume":"46","author":"Wang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0420","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.joca.2017.02.032","article-title":"A randomised double-blind placebo-controlled crossover trial of humira (Adalimumab) for erosive hand osteoarthritis: the humor trial","volume":"25","author":"Aitken","year":"2017","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0425","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrrheum.2013.160","article-title":"Role of cytokines in intervertebral disc degeneration: pain and disc content","volume":"10","author":"Risbud","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"10.1016\/j.jconrel.2020.08.041_bb0430","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1136\/ard.2003.016451","article-title":"Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study","volume":"63","author":"Genevay","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.041_bb0435","doi-asserted-by":"crossref","first-page":"582","DOI":"10.7326\/0003-4819-156-8-201204170-00009","article-title":"Active surveillance in men with localized prostate cancer: a systematic review","volume":"156","author":"Dahabreh","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0440","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/BSD.0b013e31819afdc4","article-title":"Tumor necrosis alpha-blocking agent (etanercept): a triple blind randomized controlled trial of its use in treatment of sciatica","volume":"23","author":"Okoro","year":"2010","journal-title":"J. Spinal Disord. Tech."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0445","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/art.38896","article-title":"Combined inhibition of tumor necrosis factor alpha and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody","volume":"67","author":"Fischer","year":"2015","journal-title":"Arthrit. Rheumatol."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0450","first-page":"S62","article-title":"Blockade of both Il-1a and Il-1b by a combination of monoclonal antibodies prevents the development and reverses established pain in a preclinical model of osteoarthritis","volume":"20","author":"Kamath","year":"2012","journal-title":"Osteoarthr. Cartil."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0455","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S1471-4892(01)00055-8","article-title":"The inhibition of metalloproteinases as a therapeutic target in rheumatoid arthritis and osteoarthritis","volume":"1","author":"Bigg","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0460","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.bjp.0701150","article-title":"Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo","volume":"121","author":"Lewis","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.041_bb0465","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/joca.2001.0472","article-title":"Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors","volume":"9","author":"Janusz","year":"2001","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0470","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1749-6632.1999.tb07685.x","article-title":"Clinical trials of a stromelysin inhibitor. Osteoarthritis, matrix metalloproteinase inhibition, cartilage loss, surrogate markers, and clinical implications","volume":"878","author":"Leff","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0475","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8","article-title":"Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1)","volume":"43","author":"Dahlberg","year":"2000","journal-title":"Arthrit. Rheumat."},{"issue":"38","key":"10.1016\/j.jconrel.2020.08.041_bb0480","doi-asserted-by":"crossref","first-page":"27781","DOI":"10.1074\/jbc.M703286200","article-title":"Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects","volume":"282","author":"Johnson","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0485","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/art.24629","article-title":"A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models","volume":"60","author":"Baragi","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0490","doi-asserted-by":"crossref","DOI":"10.1186\/ar4133","article-title":"MMP13 is a critical target gene during the progression of osteoarthritis","volume":"15","author":"Wang","year":"2013","journal-title":"Arthrit. Res. Ther."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0495","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/j.joca.2018.02.402","article-title":"The anti-adamts-5 nanobody (R), M6495, protects against cartilage breakdown in cartilage and synovial joint tissue explant models","volume":"26","author":"Siebuhr","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0500","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.joca.2019.02.126","article-title":"The anti-adamts-5 nanobody (R), M6495, inhibits the activation of Tlr by Adamts-5-mediated degradation fragments in cartilage explants","volume":"27","author":"Sharma","year":"2019","journal-title":"Osteoarthr. Cartil."},{"issue":"11","key":"10.1016\/j.jconrel.2020.08.041_bb0505","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.51.11.1219","article-title":"Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases","volume":"51","author":"Farrell","year":"1992","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.jconrel.2020.08.041_bb0510","first-page":"2002","article-title":"Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors","volume":"26","author":"Pelletier","year":"1999","journal-title":"J. Rheumatol."},{"issue":"11","key":"10.1016\/j.jconrel.2020.08.041_bb0515","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.joca.2004.08.005","article-title":"Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis","volume":"12","author":"El Hajjaji","year":"2004","journal-title":"Osteoarthr. Cartil."},{"issue":"10","key":"10.1016\/j.jconrel.2020.08.041_bb0520","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1002\/art.22075","article-title":"Oral salmon calcitonin reduces Lequesne\u2019s algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis","volume":"54","author":"Manicourt","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0525","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.joca.2009.08.004","article-title":"The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study","volume":"18","author":"Karsdal","year":"2010","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0530","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2474-11-232","article-title":"Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis","volume":"11","author":"Hunter","year":"2010","journal-title":"BMC Musculoskelet. Disord."},{"issue":"25","key":"10.1016\/j.jconrel.2020.08.041_bb0535","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1097\/01.brs.0000248428.22823.86","article-title":"Effects of growth differentiation factor-5 on the intervertebral disc--in vitro bovine study and in vivo rabbit disc degeneration model study","volume":"31","author":"Chujo","year":"2006","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0540","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.brs.0000148002.68656.4d","article-title":"Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits","volume":"30","author":"An","year":"2005","journal-title":"Spine (Phila Pa 1976)"},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0545","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.brs.0000206358.66412.7b","article-title":"Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model","volume":"31","author":"Masuda","year":"2006","journal-title":"Spine"},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0550","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/joca.2002.0514","article-title":"Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors","volume":"10","author":"Ellsworth","year":"2002","journal-title":"Osteoarthr. Cartil."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0555","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.joca.2005.03.003","article-title":"Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis","volume":"13","author":"Moore","year":"2005","journal-title":"Osteoarthr. Cartil."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0560","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.gt.3302196","article-title":"Osteoarthritis gene therapy","volume":"11","author":"Evans","year":"2004","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0565","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/14712598.2016.1124084","article-title":"Gene therapy for human osteoarthritis: principles and clinical translation","volume":"16","author":"Madry","year":"2016","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0570","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/humc.2014.145","article-title":"A multicenter, single-blind, phase IIa clinical trial to evaluate the efficacy and safety of a cell-mediated gene therapy in degenerative knee arthritis patients","volume":"26","author":"Ha","year":"2015","journal-title":"Human Gene Ther. Clin. Dev."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0575","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1302\/0301-620X.97B7.35852","article-title":"A placebo-controlled randomised trial to assess the effect of TGF-ss1-expressing chondrocytes in patients with arthritis of the knee","volume":"97-B","author":"Lee","year":"2015","journal-title":"Bone Joint J."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb0580","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1359-6446(01)01685-3","article-title":"Direct gene delivery strategies for the treatment of rheumatoid arthritis","volume":"6","author":"Ghivizzani","year":"2001","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0585","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41434-018-0004-0","article-title":"Understanding the molecular biology of intervertebral disc degeneration and potential gene therapy strategies for regeneration: a review","volume":"25","author":"Sampara","year":"2018","journal-title":"Gene Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.041_bb0590","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar2851","article-title":"Effect of small interference RNA (siRNA) for ADAMTS5 on intervertebral disc degeneration in the rabbit anular needle-puncture model","volume":"11","author":"Seki","year":"2009","journal-title":"Arthrit. Res. Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.041_bb0595","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/art.30251","article-title":"Caspase 3 as a therapeutic target for regulation of intervertebral disc degeneration in rabbits","volume":"63","author":"Sudo","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"35","key":"10.1016\/j.jconrel.2020.08.041_bb0600","doi-asserted-by":"crossref","first-page":"26900","DOI":"10.1074\/jbc.M110.115105","article-title":"MicroRNA-221 regulates chondrogenic differentiation through promoting proteosomal degradation of slug by targeting Mdm2","volume":"285","author":"Kim","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.jconrel.2020.08.041_bb0605","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1016\/j.biomaterials.2012.03.025","article-title":"The role of microRNA-23b in the differentiation of MSC into chondrocyte by targeting protein kinase A signaling","volume":"33","author":"Ham","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0610","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar4164","article-title":"MicroRNA-125b regulates the expression of aggrecanase-1 (ADAMTS-4) in human osteoarthritic chondrocytes","volume":"15","author":"Matsukawa","year":"2013","journal-title":"Arthrit. Res. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0615","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.devcel.2012.12.016","article-title":"MicroRNA-92a upholds Bmp signaling by targeting noggin3 during pharyngeal cartilage formation","volume":"24","author":"Ning","year":"2013","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb0620","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.joca.2015.12.012","article-title":"MicroRNA-320 regulates matrix metalloproteinase-13 expression in chondrogenesis and interleukin-1beta-induced chondrocyte responses","volume":"24","author":"Meng","year":"2016","journal-title":"Osteoarthr. Cartil."},{"issue":"12","key":"10.1016\/j.jconrel.2020.08.041_bb0625","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86820","article-title":"Identification of microRNA-181a-5p and microRNA-4454 as mediators of facet cartilage degeneration","volume":"1","author":"Nakamura","year":"2016","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.041_bb0630","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-016-0604-x","article-title":"The role of MicroRNAs and their targets in osteoarthritis","volume":"18","author":"Sondag","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0635","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.joca.2013.11.006","article-title":"Overexpression of hsa-miR-148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes","volume":"22","author":"Vonk","year":"2014","journal-title":"Osteoarthr. Cartil."},{"issue":"17","key":"10.1016\/j.jconrel.2020.08.041_bb0640","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1016\/j.febslet.2006.06.080","article-title":"The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells","volume":"580","author":"Tuddenham","year":"2006","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.jconrel.2020.08.041_bb0645","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1101\/gad.1915510","article-title":"MicroRNA-140 plays dual roles in both cartilage development and homeostasis","volume":"24","author":"Miyaki","year":"2010","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.jconrel.2020.08.041_bb0650","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1038\/mtna.2016.64","article-title":"microRNA-140 inhibits inflammation and stimulates chondrogenesis in a model of interleukin 1beta-induced osteoarthritis","volume":"5","author":"Karlsen","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"10","key":"10.1016\/j.jconrel.2020.08.041_bb0655","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.joca.2017.06.002","article-title":"Intra-articular injection of microRNA-140 (miRNA-140) alleviates osteoarthritis (OA) progression by modulating extracellular matrix (ECM) homeostasis in rats","volume":"25","author":"Si","year":"2017","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0660","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/annrheumdis-2018-213629","article-title":"microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints","volume":"78","author":"Nakamura","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0665","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/jbmr.2753","article-title":"Dysregulated miR-98 contributes to extracellular matrix degradation by targeting IL-6\/STAT3 signaling pathway in human intervertebral disc degeneration","volume":"31","author":"Ji","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0670","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00109-015-1371-2","article-title":"Downregulation of microRNA-193a-3p is involved in invertebral disc degeneration by targeting MMP14","volume":"94","author":"Ji","year":"2016","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0675","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1038\/s41467-018-07360-1","article-title":"Preclinical development of a microRNA-based therapy for intervertebral disc degeneration","volume":"9","author":"Ji","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0680","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jconrel.2017.03.004","article-title":"A hyaluronic acid-based hydrogel enabling CD44-mediated chondrocyte binding and gapmer oligonucleotide release for modulation of gene expression in osteoarthritis","volume":"253","author":"Cai","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.041_bb0685","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2018.12.030","article-title":"Fibrin-hyaluronic acid hydrogel-based delivery of antisense oligonucleotides for ADAMTS5 inhibition in co-delivered and resident joint cells in osteoarthritis","volume":"294","author":"Garcia","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.041_bb0690","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2019.07.040","article-title":"Hydrogel-based delivery of antimiR-221 enhances cartilage regeneration by endogenous cells","volume":"309","author":"Lolli","year":"2019","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0695","first-page":"16","article-title":"Emerging roles of long noncoding RNA in chondrogenesis, osteogenesis, and osteoarthritis","volume":"11","author":"Sun","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0700","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.joca.2018.12.015","article-title":"Identification of long non-coding RNAs expressed in knee and hip osteoarthritic cartilage","volume":"27","author":"Ajekigbe","year":"2019","journal-title":"Osteoarthr. Cartil."},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.041_bb0705","article-title":"Altered expression of circulating MicroRNA in plasma of patients with primary osteoarthritis and in silico analysis of their pathways","volume":"9","author":"Cuadra","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jconrel.2020.08.041_bb0710","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/jor.22397","article-title":"microRNAs and cartilage","volume":"31","author":"Gibson","year":"2013","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2019.07.002","article-title":"Applications of RNA interference in the treatment of arthritis","volume":"214","author":"Rai","year":"2019","journal-title":"Transl. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0720","doi-asserted-by":"crossref","first-page":"121","DOI":"10.11005\/jbm.2016.23.3.121","article-title":"Current status and strategy of microRNA research for cartilage development and osteoarthritis pathogenesis","volume":"23","author":"Asahara","year":"2016","journal-title":"J. Bone Metab."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0725","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1016\/j.joca.2017.02.688","article-title":"Discovery of a small molecule inhibitor of the Wnt pathway (Sm04690) as a potential treatment for degenerative disc disease","volume":"25","author":"Barroga","year":"2017","journal-title":"Osteoarthr. Cartil."},{"issue":"10","key":"10.1016\/j.jconrel.2020.08.041_bb0730","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrd.2017.116","article-title":"Senescent cells: an emerging target for diseases of ageing","volume":"16","author":"Childs","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6441","key":"10.1016\/j.jconrel.2020.08.041_bb0735","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.aaw1299","article-title":"Senolytic therapies for healthy longevity","volume":"364","author":"van Deursen","year":"2019","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0740","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2198","article-title":"Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration","volume":"9","author":"Le Maitre","year":"2007","journal-title":"Arthrit. Res. Ther."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0745","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.addr.2019.08.007","article-title":"Lessons learned from intervertebral disc pathophysiology to guide rational design of sequential delivery systems for therapeutic biological factors","volume":"149-150","author":"Frapin","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0750","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.joca.2014.09.019","article-title":"Sustained efficacy of a single intra-articular dose of FX006 in a rat model of repeated localized knee arthritis","volume":"23","author":"Kumar","year":"2015","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0755","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.joca.2017.10.003","article-title":"Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA)","volume":"26","author":"Kraus","year":"2018","journal-title":"Osteoarthr. Cartil."},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.041_bb0760","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2106\/JBJS.17.00154","article-title":"Effects of a single intra-articular injection of a microsphere formulation of triamcinolone acetonide on knee osteoarthritis pain: a double-blinded, randomized, placebo-controlled, multinational study","volume":"100","author":"Conaghan","year":"2018","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0770","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2017.03.014","article-title":"Prolonged inhibition of inflammation in osteoarthritis by triamcinolone acetonide released from a polyester amide microsphere platform","volume":"253","author":"Rudnik-Jansen","year":"2017","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0775","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10717544.2019.1568625","article-title":"Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis model","volume":"26","author":"Rudnik-Jansen","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0780","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2016.11.003","article-title":"Celecoxib-loaded PEA microspheres as an auto regulatory drug-delivery system after intra-articular injection","volume":"244","author":"Janssen","year":"2016","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0785","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1080\/10717544.2018.1482971","article-title":"Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis","volume":"25","author":"Tellegen","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0790","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jconrel.2018.08.019","article-title":"Intradiscal delivery of celecoxib-loaded microspheres restores intervertebral disc integrity in a preclinical canine model","volume":"286","author":"Tellegen","year":"2018","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb0795","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.spinee.2018.10.014","article-title":"Safety of intradiscal delivery of triamcinolone acetonide by a poly(esteramide) microsphere platform in a large animal model of intervertebral disc degeneration","volume":"19","author":"Rudnik-Jansen","year":"2019","journal-title":"Spine J."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb0800","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/BSD.0b013e31818d5e55","article-title":"A preliminary report on the effects of sustained administration of corticosteroid on traumatized disc using the adult male rat model","volume":"22","author":"Ragab","year":"2009","journal-title":"J. Spinal Disord. Tech."},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.041_bb0805","article-title":"Nanocrystal-polymer particles: extended delivery carriers for osteoarthritis treatment","volume":"14","author":"Maudens","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2020.08.041_bb0810","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2018.03.007","article-title":"Nanocrystals of a potent p38 MAPK inhibitor embedded in microparticles: therapeutic effects in inflammatory and mechanistic murine models of osteoarthritis","volume":"276","author":"Maudens","year":"2018","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2020.08.041_bb0815","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijpharm.2015.02.059","article-title":"Synthesis and characterization of silk fibroin microparticles for intra-articular drug delivery","volume":"485","author":"Mwangi","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0820","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/ten.2006.0042","article-title":"Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres","volume":"13","author":"Nagae","year":"2007","journal-title":"Tissue Eng."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0825","first-page":"201","article-title":"Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee","volume":"27","author":"Saito","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"issue":"12","key":"10.1016\/j.jconrel.2020.08.041_bb0830","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1089\/ten.tea.2008.0697","article-title":"Characterization of in vivo effects of platelet-rich plasma and biodegradable gelatin hydrogel microspheres on degenerated intervertebral discs","volume":"15","author":"Sawamura","year":"2009","journal-title":"Tissue Eng. Part A"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2020.08.041_bb0835","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijpharm.2013.11.004","article-title":"Synthesis of hydrophilic intra-articular microspheres conjugated to ibuprofen and evaluation of anti-inflammatory activity on articular explants","volume":"459","author":"Bedouet","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0840","doi-asserted-by":"crossref","first-page":"R179","DOI":"10.1186\/ar3932","article-title":"IL-1ra delivered from poly(lactic-co-glycolic acid) microspheres attenuates IL-1beta-mediated degradation of nucleus pulposus in vitro","volume":"14","author":"Gorth","year":"2012","journal-title":"Arthrit. Res. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0845","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40634-014-0015-8","article-title":"In vivo retention and bioactivity of IL-1ra microspheres in the rat intervertebral disc: a preliminary investigation","volume":"1","author":"Gorth","year":"2014","journal-title":"J. Exp. Orthop."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0850","first-page":"1097","article-title":"Dual delivery for stem cell differentiation using dexamethasone and bFGF in\/on polymeric microspheres as a cell carrier for nucleus pulposus regeneration","volume":"23","author":"Liang","year":"2012","journal-title":"J. Mater. Sci."},{"issue":"12","key":"10.1016\/j.jconrel.2020.08.041_bb0855","doi-asserted-by":"crossref","first-page":"9423","DOI":"10.1016\/j.actbio.2013.08.019","article-title":"Dual release of dexamethasone and TGF-beta3 from polymeric microspheres for stem cell matrix accumulation in a rat disc degeneration model","volume":"9","author":"Liang","year":"2013","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.jconrel.2020.08.041_bb0860","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.drudis.2018.05.023","article-title":"Recent advances in intra-articular drug delivery systems for osteoarthritis therapy","volume":"23","author":"Maudens","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2020.08.041_bb0865","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2015.12.015","article-title":"Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice","volume":"498","author":"Pradal","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0870","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1023\/A:1014260513728","article-title":"Size-dependency of DL-lactide\/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium","volume":"19","author":"Horisawa","year":"2002","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0875","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijpharm.2013.08.016","article-title":"Intra-articular fate of degradable poly(ethyleneglycol)-hydrogel microspheres as carriers for sustained drug delivery","volume":"456","author":"Bedouet","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"3\u20134","key":"10.1016\/j.jconrel.2020.08.041_bb0880","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08982100701557129","article-title":"Biodistribution and clearance of intra-articular liposomes in a large animal model using a radiographic marker","volume":"17","author":"Edwards","year":"2007","journal-title":"J. Liposome Res."},{"issue":"9","key":"10.1016\/j.jconrel.2020.08.041_bb0885","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.biomaterials.2008.12.017","article-title":"Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis","volume":"30","author":"Butoescu","year":"2009","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0890","doi-asserted-by":"crossref","first-page":"B61","DOI":"10.1002\/adem.201080088","article-title":"Polymers in drug delivery-state of the art and future trends","volume":"13","author":"Grund","year":"2011","journal-title":"Adv. Eng. Mater."},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.041_bb0895","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00011-004-1273-1","article-title":"Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits","volume":"53","author":"Liggins","year":"2004","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0900","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1039\/C7NR07614B","article-title":"Self-assembled thermoresponsive nanostructures of hyaluronic acid conjugates for osteoarthritis therapy","volume":"10","author":"Maudens","year":"2018","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb0905","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmat2116","article-title":"Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage","volume":"7","author":"Rothenfluh","year":"2008","journal-title":"Nat. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0910","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1021\/acs.molpharmaceut.7b00484","article-title":"Nanoparticle properties for delivery to cartilage: the implications of disease state, synovial fluid, and off-target uptake","volume":"16","author":"Brown","year":"2019","journal-title":"Mol. Pharm."},{"issue":"469","key":"10.1016\/j.jconrel.2020.08.041_bb0915","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat8800","article-title":"Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis","volume":"10","author":"Geiger","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0920","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.joca.2012.11.011","article-title":"Pharmaceutical nanocarrier association with chondrocytes and cartilage explants: influence of surface modification and extracellular matrix depletion","volume":"21","author":"Elsaid","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0925","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Frohlich","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb0930","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0935","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2012.12.013","article-title":"Biocompatibility of engineered nanoparticles for drug delivery","volume":"166","author":"Naahidi","year":"2013","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0940","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biomaterials.2013.09.091","article-title":"Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis","volume":"35","author":"Bajpayee","year":"2014","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.041_bb0945","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/jor.22630","article-title":"Electrostatic interactions enable rapid penetration, enhanced uptake and retention of intra-articular injected avidin in rat knee joints","volume":"32","author":"Bajpayee","year":"2014","journal-title":"J. Orthop. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0950","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.joca.2015.07.010","article-title":"Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term","volume":"24","author":"Bajpayee","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2020.08.041_bb0955","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.actbio.2018.03.032","article-title":"Stromal cell-derived factor-1alpha-encapsulated albumin\/heparin nanoparticles for induced stem cell migration and intervertebral disc regeneration in vivo","volume":"72","author":"Zhang","year":"2018","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.jconrel.2020.08.041_bb0960","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.nano.2010.05.005","article-title":"Advances in polymeric micelles for drug delivery and tumor targeting","volume":"6","author":"Kedar","year":"2010","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb0965","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s13346-015-0234-2","article-title":"Particle-based technologies for osteoarthritis detection and therapy","volume":"6","author":"Kavanaugh","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"issue":"37","key":"10.1016\/j.jconrel.2020.08.041_bb0970","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1016\/j.biomaterials.2014.08.041","article-title":"Intra-articular administration of gelatin hydrogels incorporating rapamycin-micelles reduces the development of experimental osteoarthritis in a murine model","volume":"35","author":"Matsuzaki","year":"2014","journal-title":"Biomaterials"},{"issue":"13\u201314","key":"10.1016\/j.jconrel.2020.08.041_bb0975","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/ten.tea.2016.0524","article-title":"Hyaluronic acid hydrogel functionalized with self-assembled micelles of amphiphilic PEGylated kartogenin for the treatment of osteoarthritis","volume":"23","author":"Kang","year":"2017","journal-title":"Tissue Eng. Part A"},{"issue":"29","key":"10.1016\/j.jconrel.2020.08.041_bb0980","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1002\/anie.201202713","article-title":"Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis","volume":"51","author":"Crielaard","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb0985","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1021\/nn4048205","article-title":"Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes","volume":"8","author":"Quan","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.08.041_bb0990","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2016.03.035","article-title":"Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis","volume":"230","author":"Wang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.041_bb0995","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biomaterials.2017.01.008","article-title":"Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy","volume":"122","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.08.041_bb1000","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejps.2013.09.013","article-title":"Synthesis and evaluation of cyclosporine A-loaded polysialic acid-polycaprolactone micelles for rheumatoid arthritis","volume":"51","author":"Wilson","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2020.08.041_bb1005","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1007\/s11095-007-9322-4","article-title":"Local delivery of indomethacin to arthritis-bearing rats through polymeric micelles based on amphiphilic polyphosphazenes","volume":"24","author":"Zhang","year":"2007","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb1010","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1080\/10717544.2018.1472677","article-title":"Folate receptor-targeted mixed polysialic acid micelles for combating rheumatoid arthritis: in vitro and in vivo evaluation","volume":"25","author":"Zhang","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.08.041_bb1015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.omtn.2019.02.012","article-title":"Treatment of intervertebral disk disease by the administration of mRNA encoding a cartilage-anabolic transcription factor","volume":"16","author":"Lin","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"issue":"21","key":"10.1016\/j.jconrel.2020.08.041_bb1020","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800623","article-title":"Sustained and bioresponsive two-stage delivery of therapeutic miRNA via polyplex micelle-loaded injectable hydrogels for inhibition of intervertebral disc fibrosis","volume":"7","author":"Feng","year":"2018","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb1025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb1030","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb1035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil(R)--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.041_bb1040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00143","article-title":"The use of lipid-based nanocarriers for targeted pain therapies","volume":"4","author":"Hua","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb1045","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/art.1780400518","article-title":"In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes","volume":"40","author":"Tomita","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2020.08.041_bb1050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2009.04.025","article-title":"Liposomal dexamethasone-diclofenac combinations for local osteoarthritis treatment","volume":"376","author":"Elron-Gross","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb1055","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bbamem.2008.01.002","article-title":"Cyclooxygenase inhibition by diclofenac formulated in bioadhesive carriers","volume":"1778","author":"Elron-Gross","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2020.08.041_bb1060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2012.11.031","article-title":"Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model","volume":"441","author":"Dong","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"7\u20138","key":"10.1016\/j.jconrel.2020.08.041_bb1065","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.wear.2009.12.037","article-title":"Liposomes as potential biolubricant additives for wear reduction in human synovial joints","volume":"268","author":"Verberne","year":"2010","journal-title":"Wear"},{"key":"10.1016\/j.jconrel.2020.08.041_bb1070","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.joca.2014.02.367","article-title":"Safety and efficacy of mm-ii, an intra-articular injection of liposomes, in moderate knee osteoarthritis. Prospective randomized double-blinded study","volume":"22","author":"Kandel","year":"2014","journal-title":"Osteoarthr. Cartil."},{"issue":"11","key":"10.1016\/j.jconrel.2020.08.041_bb1075","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/BRS.0b013e31805471a3","article-title":"Nucleus pulposus cellular longevity by telomerase gene therapy","volume":"32","author":"Chung","year":"2007","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb1080","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.spinee.2018.10.016","article-title":"Efficiency of dual siRNA-mediated gene therapy for intervertebral disc degeneration (IVDD)","volume":"19","author":"Banala","year":"2019","journal-title":"Spine J."},{"issue":"7","key":"10.1016\/j.jconrel.2020.08.041_bb1085","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1021\/nl401376w","article-title":"Reconstructed stem cell nanoghosts: a natural tumor targeting platform","volume":"13","author":"Toledano Furman","year":"2013","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb1090","doi-asserted-by":"crossref","DOI":"10.3390\/cells8040307","article-title":"Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes","volume":"8","author":"Gurunathan","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.041_bb1095","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.polymer.2008.01.027","article-title":"Hydrogels in drug delivery: progress and challenges","volume":"49","author":"Hoare","year":"2008","journal-title":"Polymer"},{"issue":"12","key":"10.1016\/j.jconrel.2020.08.041_bb1100","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"10","key":"10.1016\/j.jconrel.2020.08.041_bb1105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10856-019-6318-7","article-title":"Overview of natural hydrogels for regenerative medicine applications","volume":"30","author":"Catoira","year":"2019","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.041_bb1110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.smim.2007.11.004","article-title":"Foreign body reaction to biomaterials","volume":"20","author":"Anderson","year":"2008","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jconrel.2020.08.041_bb1115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1746-6148-9-68","article-title":"Injectable hyaluronic-acid-doxycycline hydrogel therapy in experimental rabbit osteoarthritis","volume":"9","author":"Lu","year":"2013","journal-title":"BMC Vet. Res."},{"issue":"28","key":"10.1016\/j.jconrel.2020.08.041_bb1120","doi-asserted-by":"crossref","first-page":"8144","DOI":"10.1016\/j.biomaterials.2014.06.017","article-title":"The effect of hyaluronan-based delivery of stromal cell-derived factor-1 on the recruitment of MSCs in degenerating intervertebral discs","volume":"35","author":"Pereira","year":"2014","journal-title":"Biomaterials"},{"issue":"24","key":"10.1016\/j.jconrel.2020.08.041_bb1125","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.2174\/1381612823666170516144914","article-title":"Bioresponsive injectable hydrogels for on-demand drug release and tissue engineering","volume":"23","author":"Vashist","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.jconrel.2020.08.041_bb1130","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/acs.biomac.9b00043","article-title":"Thermosensitive hydrogels as scaffolds for cartilage tissue engineering","volume":"20","author":"Zhang","year":"2019","journal-title":"Biomacromolecules"},{"issue":"27","key":"10.1016\/j.jconrel.2020.08.041_bb1135","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1016\/j.biomaterials.2014.05.064","article-title":"Release behavior and intra-articular biocompatibility of celecoxib-loaded acetyl-capped PCLA-PEG-PCLA thermogels","volume":"35","author":"Petit","year":"2014","journal-title":"Biomaterials"},{"issue":"32","key":"10.1016\/j.jconrel.2020.08.041_bb1140","doi-asserted-by":"crossref","first-page":"8002","DOI":"10.1016\/j.biomaterials.2013.07.046","article-title":"In situ forming acyl-capped PCLA-PEG-PCLA triblock copolymer based hydrogels","volume":"34","author":"Sandker","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.08.041_bb1145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.biomaterials.2015.02.109","article-title":"Sustained intra-articular release of celecoxib from in situ forming gels made of acetyl-capped PCLA-PEG-PCLA triblock copolymers in horses","volume":"53","author":"Petit","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.08.041_bb1150","article-title":"Towards an arthritis flare-responsive drug delivery system","volume":"9","author":"Joshi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2020.08.041_bb1155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13075-015-0727-x","article-title":"Biocompatibility and intradiscal application of a thermoreversible celecoxib-loaded poly-N-isopropylacrylamide MgFe-layered double hydroxide hydrogel in a canine model","volume":"17","author":"Willems","year":"2015","journal-title":"Arthrit. Res. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb1160","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1089\/biores.2015.0025","article-title":"BMP-2 and BMP-2\/7 heterodimers conjugated to a fibrin\/hyaluronic acid hydrogel in a large animal model of mild intervertebral disc degeneration","volume":"4","author":"Peeters","year":"2015","journal-title":"Biores Open Access"},{"key":"10.1016\/j.jconrel.2020.08.041_bb1165","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.actbio.2015.05.018","article-title":"A novel injectable thermoresponsive and cytocompatible gel of poly(N-isopropylacrylamide) with layered double hydroxides facilitates siRNA delivery into chondrocytes in 3D culture","volume":"23","author":"Yang","year":"2015","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.041_bb1170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jor.24136","article-title":"Targeting anti-chondrogenic factors for the stimulation of chondrogenesis: a new paradigm in cartilage repair","volume":"37","author":"Lolli","year":"2019","journal-title":"J. Orthop. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2020.08.041_bb1175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3171\/SPI\/2008\/9\/9\/307","article-title":"Biomechanical evaluation of conventional anulus fibrosus closure methods required for nucleus replacement. Laboratory investigation","volume":"9","author":"Heuer","year":"2008","journal-title":"J. Neurosurg. Spine"},{"key":"10.1016\/j.jconrel.2020.08.041_bb1180","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1007\/s00586-006-0177-x","article-title":"Is a collagen scaffold for a tissue engineered nucleus replacement capable of restoring disc height and stability in an animal model?","volume":"15","author":"Wilke","year":"2006","journal-title":"Eur. Spine J."},{"key":"10.1016\/j.jconrel.2020.08.041_bb1185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.actbio.2017.07.025","article-title":"Translation of an injectable triple-interpenetrating-network hydrogel for intervertebral disc regeneration in a goat model","volume":"60","author":"Gullbrand","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2020.08.041_bb1190","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.actbio.2017.03.010","article-title":"Thermally triggered hydrogel injection into bovine intervertebral disc tissue explants induces differentiation of mesenchymal stem cells and restores mechanical function","volume":"54","author":"Thorpe","year":"2017","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.jconrel.2020.08.041_bb1195","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/art.39049","article-title":"Use of recombinant human stromal cell-derived factor 1alpha-loaded fibrin\/hyaluronic acid hydrogel networks to achieve functional repair of full-thickness bovine articular cartilage via homing of chondrogenic progenitor cells","volume":"67","author":"Yu","year":"2015","journal-title":"Arthrit. Rheumatol."},{"issue":"9739","key":"10.1016\/j.jconrel.2020.08.041_bb1200","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(10)60668-X","article-title":"Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study","volume":"376","author":"Lee","year":"2010","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.jconrel.2020.08.041_bb1205","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/BRS.0b013e3181788760","article-title":"Regeneration of intervertebral disc tissue by resorbable cell-free polyglycolic acid-based implants in a rabbit model of disc degeneration","volume":"33","author":"Abbushi","year":"2008","journal-title":"Spine (Phila Pa 1976)"},{"issue":"22","key":"10.1016\/j.jconrel.2020.08.041_bb1210","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1016\/j.biomaterials.2010.03.078","article-title":"Intervertebral disc regeneration after implantation of a cell-free bioresorbable implant in a rabbit disc degeneration model","volume":"31","author":"Endres","year":"2010","journal-title":"Biomaterials"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592030482X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592030482X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T23:16:07Z","timestamp":1718406967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592030482X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":241,"alternative-id":["S016836592030482X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.041","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug delivery in intervertebral disc degeneration and osteoarthritis: Selecting the optimal platform for the delivery of disease-modifying agents","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}